The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB.
Malaisamy MuniyandiParanchi Murugesan RameshWilliam A WellsUmesh AlavadiSuvanand SahuPadmapriyadarsini ChandrasekaranPublished in: Tropical medicine and infectious disease (2023)
As a lower-cost intervention with improved health outcomes, the BEAT-TB India regimen is dominant when compared to the 18-month regimen.